Paroxysmal nocturnal hemoglobinuria (PNH) is a hematological disorder due to a defect in the glycosylphosphatidylinositol (GPI) anchor which is caused by somatic mutations of the PIGA gene. Nocturnal hemoglobinuria is the first symptom, but other hematological abnormalities up to a myelodysplastic syndrome might ensue.
Eculizumab seems to be a new quite effective medicament.
| 1. |
Ueda E et al. (1992) Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria.
|
| 2. |
Socié G et al. (1996) Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology.
|
| 3. |
None (1996) Epidemiology of PNH.
|
| 4. |
Yeh ET et al. (1994) Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor.
|
| 5. |
Bessler M et al. (1994) Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria.
|
| 6. |
Hillmen P et al. (1995) Natural history of paroxysmal nocturnal hemoglobinuria.
|
| 7. |
None (1989) Paroxysmal nocturnal hemoglobinuria: the biochemical defects and the clinical syndrome.
|
| 8. |
van den Heuvel-Eibrink MM et al. (2005) Childhood paroxysmal nocturnal haemoglobinuria (PNH), a report of 11 cases in the Netherlands.
|
| 9. |
Hillmen P et al. (2004) Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
|
| 10. |
Hirose S et al. (1992) Synthesis of mannosylglucosaminylinositol phospholipids in normal but not paroxysmal nocturnal hemoglobinuria cells.
|
| 11. |
Mahoney JF et al. (1992) Defective glycosylphosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes.
|
| 13. |
Horikawa K et al. (2002) Frequent detection of T cells with mutations of the hypoxanthine-guanine phosphoribosyl transferase gene in patients with paroxysmal nocturnal hemoglobinuria.
|
| 14. |
Nishimura J et al. (1999) Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease.
|
| 15. |
Brodsky RA et al. (1997) Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria.
|
| 16. |
Luzzatto L et al. (1997) Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise?
|
| 17. |
Savoia A et al. (1996) Identification of three novel mutations in the PIG-A gene in paroxysmal nocturnal haemoglobinuria (PNH) patients.
|
| 18. |
Nagarajan S et al. (1995) Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia.
|
| 19. |
Takeda J et al. (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.
|
| 21. |
Bessler M et al. (1994) Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene.
|
| 22. |
Ware RE et al. (1994) Chromosomal assignment of genes involved in glycosylphosphatidylinositol anchor biosynthesis: implications for the pathogenesis of paroxysmal nocturnal hemoglobinuria.
|
| 23. |
None (2008) Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria.
|
| 24. |
Hu R et al. (2005) PIG-A mutations in normal hematopoiesis.
|
| 25. |
Araten DJ et al. (1999) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals.
|
| 26. |
Orphanet article Orphanet ID 447
|
| 27. |
OMIM.ORG article Omim 300818
|
| 28. |
Wikipedia article Wikipedia EN (Paroxysmal_nocturnal_hemoglobinuria)
|